![Sergio Santillana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sergio Santillana
Gründer bei Slss Consulting LLC
Vermögen: - $ am 31.05.2024
Profil
Sergio L.
Santillana is the founder of Slss Consulting LLC.
He previously worked as the Director-Clinical Development at GSK Plc from 2012 to 2014.
From 2014 to 2016, he served as the Senior Medical Director at Takeda Pharmaceuticals International, Inc. In 2016, he held the position of Chief Medical Officer at ARIAD Pharmaceuticals, Inc. From 2017 to 2019, he worked as the Chief Medical Officer & Senior Vice President at Merrimack Pharmaceuticals, Inc. Currently, he is the Chief Medical Officer at Ikena Oncology, Inc. Dr. Santillana completed his undergraduate and doctorate degrees at Universidad Nacional Federico Villarreal.
He also holds an MBA from MIT Sloan School of Management and a graduate degree from Kellogg College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IKENA ONCOLOGY, INC.
-.--% | 01.04.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Sergio Santillana
Unternehmen | Position | Beginn |
---|---|---|
Slss Consulting LLC | Gründer | - |
Ehemalige bekannte Positionen von Sergio Santillana
Unternehmen | Position | Ende |
---|---|---|
IKENA ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.02.2024 |
MERRIMACK PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.04.2019 |
ARIAD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 |
Takeda Pharmaceuticals International, Inc.
![]() Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01.03.2016 |
GSK PLC | Corporate Officer/Principal | 01.08.2014 |
Ausbildung von Sergio Santillana
Universidad Nacional Federico Villarreal | Doctorate Degree |
MIT Sloan School of Management | Masters Business Admin |
Kellogg College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
IKENA ONCOLOGY, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Takeda Pharmaceuticals International, Inc.
![]() Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Commercial Services |
Slss Consulting LLC |